Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Publications indexed to the term T-Lymphocyte Subsets

2How I Diagnose Mature T-Cell Proliferations by Flow Cytometry. (Kroft SH, Harrington AM) Am J Clin Pathol 2022 Oct 06;158(4):456-471    
1Increased homeostatic cytokines and stability of HIV-infected memory CD4 T-cells identify individuals with suboptimal CD4 T-cell recovery on-ART. (Pino M, Pereira Ribeiro S, Pagliuzza A, Ghneim K, Khan A, Ryan E, Harper JL, King CT, Welbourn S, Micci L, Aldrete S, Delman KA, Stuart T, Lowe M, Brenchley JM, Derdeyn CA, Easley K, Sekaly RP, Chomont N, Paiardini M, Marconi VC) PLoS Pathog 2021 Aug;17(8):e1009825       11 Citations
1Clonally Focused Public and Private T Cells in Resected Brain Tissue From Surgeries to Treat Children With Intractable Seizures. (Chang JW, Reyes SD, Faure-Kumar E, Lam SK, Lawlor MW, Leventer RJ, Lew SM, Lockhart PJ, Pope K, Weiner HL, Salamon N, Vinters HV, Mathern GW, Fallah A, Owens GC) Front Immunol 2021;12:664344       3 Citations
1CD4+CD25+CD127hi cell frequency predicts disease progression in type 1 diabetes. (Narsale A, Lam B, Moya R, Lu T, Mandelli A, Gotuzzo I, Pessina B, Giamporcaro G, Geoffrey R, Buchanan K, Harris M, Bergot AS, Thomas R, Hessner MJ, Battaglia M, Serti E, Davies JD) JCI Insight 2021 Jan 25;6(2)       10 Citations
1Tumor-intrinsic and -extrinsic determinants of response to blinatumomab in adults with B-ALL. (Zhao Y, Aldoss I, Qu C, Crawford JC, Gu Z, Allen EK, Zamora AE, Alexander TB, Wang J, Goto H, Imamura T, Akahane K, Marcucci G, Stein AS, Bhatia R, Thomas PG, Forman SJ, Mullighan CG, Roberts KG) Blood 2021 Jan 28;137(4):471-484       55 Citations
1Targeting the Complement Alternative Pathway Permits Graft Versus Leukemia Activity while Preventing Graft Versus Host Disease. (Nguyen H, Alawieh A, Bastian D, Kuril S, Dai M, Daenthanasanmak A, Zhang M, Iamsawat S, Schutt SD, Wu Y, Sleiman MM, Shetty A, Atkinson C, Sun S, Varela JC, Tomlinson S, Yu XZ) Clin Cancer Res 2020 Jul 01;26(13):3481-3490       7 Citations
1Soluble CD137 Ameliorates Acute Type 1 Diabetes by Inducing T Cell Anergy. (Itoh A, Ortiz L, Kachapati K, Wu Y, Adams D, Bednar K, Mukherjee S, Chougnet C, Mittler RS, Chen YG, Dolan L, Ridgway WM) Front Immunol 2019;10:2566       11 Citations
2CXCR5+PD-1+ follicular helper CD8 T cells control B cell tolerance. (Chen Y, Yu M, Zheng Y, Fu G, Xin G, Zhu W, Luo L, Burns R, Li QZ, Dent AL, Zhu N, Cui W, Malherbe L, Wen R, Wang D) Nat Commun 2019 Sep 27;10(1):4415       53 Citations
1Could the menagerie of the gut microbiome really cure cancer? Hope or hype. (Abid MB) J Immunother Cancer 2019 Apr 02;7(1):92       13 Citations
1Immune Response to Brugia malayi Asparaginyl-tRNA Synthetase in Balb/c Mice and Human Clinical Samples of Lymphatic Filariasis. (Hameed A, Natarajan M, Jabbar S, Dhanasekaran JJ, Kumar K, Sivanesan S, Kron M, Dhanasekaran A) Lymphat Res Biol 2019 Aug;17(4):447-456       2 Citations
1Adoptive cell therapy using PD-1+ myeloma-reactive T cells eliminates established myeloma in mice. (Jing W, Gershan JA, Blitzer GC, Palen K, Weber J, McOlash L, Riese M, Johnson BD) J Immunother Cancer 2017;5:51       20 Citations
1Blocking Indolamine-2,3-Dioxygenase Rebound Immune Suppression Boosts Antitumor Effects of Radio-Immunotherapy in Murine Models and Spontaneous Canine Malignancies. (Monjazeb AM, Kent MS, Grossenbacher SK, Mall C, Zamora AE, Mirsoian A, Chen M, Kol A, Shiao SL, Reddy A, Perks JR, T N Culp W, Sparger EE, Canter RJ, Sckisel GD, Murphy WJ) Clin Cancer Res 2016 Sep 01;22(17):4328-40       84 Citations
1Tumoricidal Effects of Macrophage-Activating Immunotherapy in a Murine Model of Relapsed/Refractory Multiple Myeloma. (Jensen JL, Rakhmilevich A, Heninger E, Broman AT, Hope C, Phan F, Miyamoto S, Maroulakou I, Callander N, Hematti P, Chesi M, Bergsagel PL, Sondel P, Asimakopoulos F) Cancer Immunol Res 2015 Aug;3(8):881-90       24 Citations
3Structure-function analysis of CCL28 in the development of post-viral asthma. (Thomas MA, Buelow BJ, Nevins AM, Jones SE, Peterson FC, Gundry RL, Grayson MH, Volkman BF) J Biol Chem 2015 Feb 13;290(7):4528-36       16 Citations
1The role of the microbiome in immune cell development. (Salzman NH) Ann Allergy Asthma Immunol 2014 Dec;113(6):593-8       19 Citations
2Upholding the T cell immune-regulatory function of CD31 inhibits the formation of T/B immunological synapses in vitro and attenuates the development of experimental autoimmune arthritis in vivo. (Clement M, Fornasa G, Loyau S, Morvan M, Andreata F, Guedj K, Khallou-Laschet J, Larghi P, Le Roux D, Bismuth G, Chiocchia G, Hivroz C, Newman DK, Nicoletti A, Caligiuri G) J Autoimmun 2015 Jan;56:23-33       18 Citations
1Helper T-cell differentiation in graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. (Fu J, Heinrichs J, Yu XZ) Arch Immunol Ther Exp (Warsz) 2014 Aug;62(4):277-301       21 Citations
4Chronic follicular bronchiolitis requires antigen-specific regulatory T cell control to prevent fatal disease progression. (Schmitt EG, Haribhai D, Jeschke JC, Co DO, Ziegelbauer J, Yan K, Iwakura Y, Mishra MK, Simpson P, Salzman NH, Williams CB) J Immunol 2013 Dec 01;191(11):5460-76       4 Citations
1Alterations in circulating T-cell lymphocyte populations in children with obstructive sleep apnea. (Tan HL, Gozal D, Wang Y, Bandla HP, Bhattacharjee R, Kulkarni R, Kheirandish-Gozal L) Sleep 2013 Jun 01;36(6):913-22       40 Citations
1Phosphatidylinositol 3-kinase-independent signaling pathways contribute to ICOS-mediated T cell costimulation in acute graft-versus-host disease in mice. (Li J, Heinrichs J, Leconte J, Haarberg K, Semple K, Liu C, Gigoux M, Kornete M, Piccirillo CA, Suh WK, Yu XZ) J Immunol 2013 Jul 01;191(1):200-7       20 Citations
2Genetic control of murine invariant natural killer T cells maps to multiple type 1 diabetes regions. (Tsaih SW, Khaja S, Ciecko AE, MacKinney E, Chen YG) Genes Immun 2013 Sep;14(6):380-6       4 Citations
1Premature cell senescence and T cell receptor-independent activation of CD8+ T cells in juvenile idiopathic arthritis. (Dvergsten JA, Mueller RG, Griffin P, Abedin S, Pishko A, Michel JJ, Rosenkranz ME, Reed AM, Kietz DA, Vallejo AN) Arthritis Rheum 2013 Aug;65(8):2201-10       29 Citations
1Th17 cells confer long-term adaptive immunity to oral mucosal Candida albicans infections. (Hernández-Santos N, Huppler AR, Peterson AC, Khader SA, McKenna KC, Gaffen SL) Mucosal Immunol 2013 Sep;6(5):900-10       138 Citations
1Lymphocyte phenotype during therapy for acute graft-versus-host disease: a brief report from BMT-CTN 0302. (Bolaños-Meade J, Wu J, Logan BR, Levine JE, Ho VT, Alousi AM, Weisdorf DJ, Luznik L, Blood and Marrow Transplant Clinical Trials Network) Biol Blood Marrow Transplant 2013 Mar;19(3):481-5       5 Citations
3Use of combination chemotherapy for treatment of granulomatous and lymphocytic interstitial lung disease (GLILD) in patients with common variable immunodeficiency (CVID). (Chase NM, Verbsky JW, Hintermeyer MK, Waukau JK, Tomita-Mitchell A, Casper JT, Singh S, Shahir KS, Tisol WB, Nugent ML, Rao RN, Mackinnon AC, Goodman LR, Simpson PM, Routes JM) J Clin Immunol 2013 Jan;33(1):30-9       168 Citations
1GB virus C viremia is associated with higher levels of double-negative T cells and lower T-cell activation in HIV-infected individuals receiving antiretroviral therapy. (Bhattarai N, Rydze RT, Chivero ET, Stapleton JT) J Infect Dis 2012 Nov;206(9):1469-72       19 Citations
2Comparative outcomes of donor graft CD34+ selection and immune suppressive therapy as graft-versus-host disease prophylaxis for patients with acute myeloid leukemia in complete remission undergoing HLA-matched sibling allogeneic hematopoietic cell transplantation. (Pasquini MC, Devine S, Mendizabal A, Baden LR, Wingard JR, Lazarus HM, Appelbaum FR, Keever-Taylor CA, Horowitz MM, Carter S, O'Reilly RJ, Soiffer RJ) J Clin Oncol 2012 Sep 10;30(26):3194-201       129 Citations
2CD8+ Foxp3+ regulatory T cells are induced during graft-versus-host disease and mitigate disease severity. (Beres AJ, Haribhai D, Chadwick AC, Gonyo PJ, Williams CB, Drobyski WR) J Immunol 2012 Jul 01;189(1):464-74       90 Citations
1Signaling through L-selectin mediates enhanced chemotaxis of lymphocyte subsets to secondary lymphoid tissue chemokine. (Subramanian H, Grailer JJ, Ohlrich KC, Rymaszewski AL, Loppnow JJ, Kodera M, Conway RM, Steeber DA) J Immunol 2012 Apr 01;188(7):3223-36       34 Citations
2Evidence for a stepwise program of extrathymic T cell development within the human tonsil. (McClory S, Hughes T, Freud AG, Briercheck EL, Martin C, Trimboli AJ, Yu J, Zhang X, Leone G, Nuovo G, Caligiuri MA) J Clin Invest 2012 Apr;122(4):1403-15       69 Citations
1T-regulatory cells in primary immune deficiencies. (Verbsky JW, Chatila TA) Curr Opin Allergy Clin Immunol 2011 Dec;11(6):539-44       21 Citations
4A requisite role for induced regulatory T cells in tolerance based on expanding antigen receptor diversity. (Haribhai D, Williams JB, Jia S, Nickerson D, Schmitt EG, Edwards B, Ziegelbauer J, Yassai M, Li SH, Relland LM, Wise PM, Chen A, Zheng YQ, Simpson PM, Gorski J, Salzman NH, Hessner MJ, Chatila TA, Williams CB) Immunity 2011 Jul 22;35(1):109-22       338 Citations
1Roles of CD28, CTLA4, and inducible costimulator in acute graft-versus-host disease in mice. (Li J, Semple K, Suh WK, Liu C, Chen F, Blazar BR, Yu XZ) Biol Blood Marrow Transplant 2011 Jul;17(7):962-9       40 Citations
1Human Vδ1 γδ T cells expanded from peripheral blood exhibit specific cytotoxicity against B-cell chronic lymphocytic leukemia-derived cells. (Siegers GM, Dhamko H, Wang XH, Mathieson AM, Kosaka Y, Felizardo TC, Medin JA, Tohda S, Schueler J, Fisch P, Keating A) Cytotherapy 2011 Jul;13(6):753-64       70 Citations
11,25-Dihydroxyvitamin D3 acts directly on the T lymphocyte vitamin D receptor to inhibit experimental autoimmune encephalomyelitis. (Mayne CG, Spanier JA, Relland LM, Williams CB, Hayes CE) Eur J Immunol 2011 Mar;41(3):822-32       137 Citations
1Ingested (oral) ACTH inhibits EAE. (Brod SA, Hood ZM) J Neuroimmunol 2011 Mar;232(1-2):131-5       21 Citations
2TCR stimulation drives cleavage and shedding of the ITIM receptor CD31. (Fornasa G, Groyer E, Clement M, Dimitrov J, Compain C, Gaston AT, Varthaman A, Khallou-Laschet J, Newman DK, Graff-Dubois S, Nicoletti A, Caligiuri G) J Immunol 2010 May 15;184(10):5485-92       50 Citations
3Phospholipase C{gamma}1 is essential for T cell development, activation, and tolerance. (Fu G, Chen Y, Yu M, Podd A, Schuman J, He Y, Di L, Yassai M, Haribhai D, North PE, Gorski J, Williams CB, Wang D, Wen R) J Exp Med 2010 Feb 15;207(2):309-18       100 Citations
1Statewide newborn screening for severe T-cell lymphopenia. (Routes JM, Grossman WJ, Verbsky J, Laessig RH, Hoffman GL, Brokopp CD, Baker MW) JAMA 2009 Dec 09;302(22):2465-70       174 Citations
1Regulation of pathogenic IL-17 responses in collagen-induced arthritis: roles of endogenous interferon-gamma and IL-4. (Sarkar S, Cooney LA, White P, Dunlop DB, Endres J, Jorns JM, Wasco MJ, Fox DA) Arthritis Res Ther 2009;11(5):R158       75 Citations
1T helper17 cells are sufficient but not necessary to induce acute graft-versus-host disease. (Iclozan C, Yu Y, Liu C, Liang Y, Yi T, Anasetti C, Yu XZ) Biol Blood Marrow Transplant 2010 Feb;16(2):170-8       87 Citations
2Antiviral responses following L-leucyl-L-leucine methyl esther (LLME)-treated lymphocyte infusions: graft-versus-infection without graft-versus-host disease. (Filicko-O'Hara J, Grosso D, Flomenberg PR, Friedman TM, Brunner J, Drobyski W, Ferber A, Kakhniashvili I, Keever-Taylor C, Mookerjee B, Talano JA, Wagner JI, Korngold R, Flomenberg N) Biol Blood Marrow Transplant 2009 Dec;15(12):1609-19       7 Citations
1Genetic association of HLA DQB1 with CD4+CD25+(high) T-cell apoptosis in type 1 diabetes. (Glisic S, Klinker M, Waukau J, Jailwala P, Jana S, Basken J, Wang T, Alemzadeh R, Hagopian W, Ghosh S) Genes Immun 2009 Jun;10(4):334-40       19 Citations
1Overexpression of CD7 in classical Hodgkin lymphoma-infiltrating T lymphocytes. (Seegmiller AC, Karandikar NJ, Kroft SH, McKenna RW, Xu Y) Cytometry B Clin Cytom 2009 May;76(3):169-74       27 Citations
1Induction of a VLA-2 (CD49b)-expressing effector T cell population by a cell-based neuroblastoma vaccine expressing CD137L. (Yan X, Johnson BD, Orentas RJ) J Immunol 2008 Oct 01;181(7):4621-31       15 Citations
2Idd9/11 genetic locus regulates diabetogenic activity of CD4 T-cells in nonobese diabetic (NOD) mice. (Chen YG, Scheuplein F, Osborne MA, Tsaih SW, Chapman HD, Serreze DV) Diabetes 2008 Dec;57(12):3273-80       18 Citations
1TGF-beta-dependent suppressive function of Tregs requires wild-type levels of CD18 in a mouse model of psoriasis. (Wang H, Peters T, Sindrilaru A, Kess D, Oreshkova T, Yu XZ, Seier AM, Schreiber H, Wlaschek M, Blakytny R, Röhrbein J, Schulz G, Weiss JM, Scharffetter-Kochanek K) J Clin Invest 2008 Jul;118(7):2629-39       55 Citations
1B7-H1 restricts neuroantigen-specific T cell responses and confines inflammatory CNS damage: implications for the lesion pathogenesis of multiple sclerosis. (Ortler S, Leder C, Mittelbronn M, Zozulya AL, Knolle PA, Chen L, Kroner A, Wiendl H) Eur J Immunol 2008 Jun;38(6):1734-44       62 Citations
1CD3+ cell dose and disease status are important factors determining clinical outcomes in patients undergoing unmanipulated haploidentical blood and marrow transplantation after conditioning including antithymocyte globulin. (Dong L, Wu T, Zhang MJ, Gao ZY, Lu DP) Biol Blood Marrow Transplant 2007 Dec;13(12):1515-24       33 Citations
1Clonal expansions of pathogenic CD8+ effector cells in the CNS of myelin mutant mice. (Leder C, Schwab N, Ip CW, Kroner A, Nave KA, Dornmair K, Martini R, Wiendl H) Mol Cell Neurosci 2007 Nov;36(3):416-24       17 Citations
1Quantitative measurement of pathogen-specific human memory T cell repertoire diversity using a CDR3 beta-specific microarray. (Wang X, Jia S, Meyer L, Yassai MB, Naumov YN, Gorski J, Hessner MJ) BMC Genomics 2007 Sep 19;8:329       4 Citations
1Dynamic changes in CD4+ CD25+(high) T cell apoptosis after the diagnosis of type 1 diabetes. (Glisic-Milosavljevic S, Wang T, Koppen M, Kramer J, Ehlenbach S, Waukau J, Jailwala P, Jana S, Alemzadeh R, Ghosh S) Clin Exp Immunol 2007 Oct;150(1):75-82       29 Citations
1Gammadelta T cells do not require fully functional cytotoxic pathways or the ability to recognize recipient alloantigens to prevent graft rejection. (Vodanovic-Jankovic S, Drobyski WR) Biol Blood Marrow Transplant 2006 Nov;12(11):1125-34       6 Citations
1T-cell tolerance or function is determined by combinatorial costimulatory signals. (Nurieva R, Thomas S, Nguyen T, Martin-Orozco N, Wang Y, Kaja MK, Yu XZ, Dong C) EMBO J 2006 Jun 07;25(11):2623-33       197 Citations
1Tracking the prevalence of transmitted antiretroviral drug-resistant HIV-1: a decade of experience. (Shet A, Berry L, Mohri H, Mehandru S, Chung C, Kim A, Jean-Pierre P, Hogan C, Simon V, Boden D, Markowitz M) J Acquir Immune Defic Syndr 2006 Apr 01;41(4):439-46       159 Citations
1Hemophagocytic lymphohistiocytosis: diagnosis, pathophysiology, treatment, and future perspectives. (Verbsky JW, Grossman WJ) Ann Med 2006;38(1):20-31       174 Citations
1Novel leptin receptor mutation in NOD/LtJ mice suppresses type 1 diabetes progression: II. Immunologic analysis. (Lee CH, Chen YG, Chen J, Reifsnyder PC, Serreze DV, Clare-Salzler M, Rodriguez M, Wasserfall C, Atkinson MA, Leiter EH) Diabetes 2006 Jan;55(1):171-8       29 Citations
1Activated NKT cells inhibit autoimmune diabetes through tolerogenic recruitment of dendritic cells to pancreatic lymph nodes. (Chen YG, Choisy-Rossi CM, Holl TM, Chapman HD, Besra GS, Porcelli SA, Shaffer DJ, Roopenian D, Wilson SB, Serreze DV) J Immunol 2005 Feb 01;174(3):1196-204       123 Citations
1Differential expression of granzymes A and B in human cytotoxic lymphocyte subsets and T regulatory cells. (Grossman WJ, Verbsky JW, Tollefsen BL, Kemper C, Atkinson JP, Ley TJ) Blood 2004 Nov 01;104(9):2840-8       400 Citations
1Host conditioning is a primary determinant in modulating the effect of IL-7 on murine graft-versus-host disease. (Gendelman M, Hecht T, Logan B, Vodanovic-Jankovic S, Komorowski R, Drobyski WR) J Immunol 2004 Mar 01;172(5):3328-36       30 Citations
1Lck is required for activation-induced T cell death after TCR ligation with partial agonists. (Yu XZ, Levin SD, Madrenas J, Anasetti C) J Immunol 2004 Feb 01;172(3):1437-43       17 Citations
1Genetic dissection of lymphopenia from autoimmunity by introgression of mutated Ian5 gene onto the F344 rat. (Moralejo DH, Park HA, Speros SJ, MacMurray AJ, Kwitek AE, Jacob HJ, Lander ES, Lernmark A) J Autoimmun 2003 Dec;21(4):315-24       32 Citations
1A threshold for central T cell tolerance to an inducible serum protein. (Haribhai D, Engle D, Meyer M, Donermeyer D, White JM, Williams CB) J Immunol 2003 Mar 15;170(6):3007-14       20 Citations
1Elimination of leukemia in the absence of lethal graft-versus-host disease after allogenic bone marrow transplantation. (Drobyski WR, Gendelman M, Vodanovic-Jankovic S, Gorski J) J Immunol 2003 Mar 15;170(6):3046-53       16 Citations
1Real-time T-cell profiling identifies H60 as a major minor histocompatibility antigen in murine graft-versus-host disease. (Choi EY, Christianson GJ, Yoshimura Y, Jung N, Sproule TJ, Malarkannan S, Joyce S, Roopenian DC) Blood 2002 Dec 15;100(13):4259-65       62 Citations
1Subunits of IgM reconstitute defective contact sensitivity in B-1 cell-deficient xid mice: kappa light chains recruit T cells independent of complement. (Paliwal V, Tsuji RF, Szczepanik M, Kawikova I, Campos RA, Kneilling M, Röcken M, Schuurman J, Redegeld FA, Nijkamp FP, Askenase PW) J Immunol 2002 Oct 15;169(8):4113-23       27 Citations
1Soluble proteins and haptens on bone marrow-derived dendritic cells are presented to host CD4 T cells in an MHC-restricted manner. (Olasz EB, Linton J, Katz SI) Int Immunol 2002 May;14(5):493-502       4 Citations
1Deficiency in beta(2)-microglobulin, but not CD1, accelerates spontaneous lupus skin disease while inhibiting nephritis in MRL-Fas(lpr) nice: an example of disease regulation at the organ level. (Chan OT, Paliwal V, McNiff JM, Park SH, Bendelac A, Shlomchik MJ) J Immunol 2001 Sep 01;167(5):2985-90       70 Citations
1Mycobacterium bovis strain bacillus Calmette-Guérin-induced liver granulomas contain a diverse TCR repertoire, but a monoclonal T cell population is sufficient for protective granuloma formation. (Hogan LH, Macvilay K, Barger B, Co D, Malkovska I, Fennelly G, Sandor M) J Immunol 2001 May 15;166(10):6367-75       32 Citations
1Anti-CD3 epsilon F(ab')2 prevents graft-versus-host disease by selectively depleting donor T cells activated by recipient alloantigens. (Yu XZ, Bidwell SJ, Martin PJ, Anasetti C) J Immunol 2001 May 01;166(9):5835-9       32 Citations
1Non-Fc receptor-binding humanized anti-CD3 antibodies induce apoptosis of activated human T cells. (Carpenter PA, Pavlovic S, Tso JY, Press OW, Gooley T, Yu XZ, Anasetti C) J Immunol 2000 Dec 01;165(11):6205-13       87 Citations
1Adoptively transferred gamma delta T cells indirectly regulate murine graft-versus-host reactivity following donor leukocyte infusion therapy in mice. (Drobyski WR, Vodanovic-Jankovic S, Klein J) J Immunol 2000 Aug 01;165(3):1634-40       36 Citations
1Ligand-specific selection of MHC class II-restricted thymocytes in fetal thymic organ culture. (Kersh GJ, Engle DL, Williams CB, Allen PM) J Immunol 2000 Jun 01;164(11):5675-82       10 Citations
1Murine CCR9, a chemokine receptor for thymus-expressed chemokine that is up-regulated following pre-TCR signaling. (Norment AM, Bogatzki LY, Gantner BN, Bevan MJ) J Immunol 2000 Jan 15;164(2):639-48       91 Citations
1Role of immunoregulatory donor T cells in suppression of graft-versus-host disease following donor leukocyte infusion therapy. (Johnson BD, Becker EE, LaBelle JL, Truitt RL) J Immunol 1999 Dec 15;163(12):6479-87       62 Citations
1Graft-vs.-host and graft-vs.-leukemia reactions after delayed infusions of donor T-subsets. (Johnson BD, Becker EE, Truitt RL) Biol Blood Marrow Transplant 1999;5(3):123-32       54 Citations
1CNS cell populations are protected from virus-induced pathology by distinct arms of the immune system. (Drescher KM, Murray PD, David CS, Pease LR, Rodriguez M) Brain Pathol 1999 Jan;9(1):21-31       23 Citations
1Ex vivo anti-CD3 antibody-activated donor T cells have a reduced ability to cause lethal murine graft-versus-host disease but retain their ability to facilitate alloengraftment. (Drobyski WR, Majewski D, Ozker K, Hanson G) J Immunol 1998 Sep 01;161(5):2610-9       45 Citations
1In vivo expression of a TCR antagonist: T cells escape central tolerance but are antagonized in the periphery. (Williams CB, Vidal K, Donermeyer D, Peterson DA, White JM, Allen PM) J Immunol 1998 Jul 01;161(1):128-37       30 Citations
2Effect of T cell subset dose on outcome of T cell-depleted bone marrow transplantation. (Kawanishi Y, Passweg J, Drobyski WR, Rowlings P, Cook-Craig A, Casper J, Pietryga D, Garbrecht F, Camitta B, Horowitz M, Juckett M, Margolis D, Flomenberg N, Keever-Taylor CA) Bone Marrow Transplant 1997 Jun;19(11):1069-77       51 Citations
1Donor gamma delta T lymphocytes promote allogeneic engraftment across the major histocompatibility barrier in mice. (Drobyski WR, Majewski D) Blood 1997 Feb 01;89(3):1100-9       39 Citations
1Modulation of in vitro and in vivo T-cell responses by transferrin-gallium and gallium nitrate. (Drobyski WR, Ul-Haq R, Majewski D, Chitambar CR) Blood 1996 Oct 15;88(8):3056-64       25 Citations
1Regulation of allergic contact sensitivity in mice: soluble alpha beta T cell receptors, derived via cDNA transfection and enzymatic cleavage from the surface of T cells, protect contact sensitivity effector T cells from active T cell suppression. (Paliwal V, Ptak W, Askenase PW) Int Arch Allergy Immunol 1995;107(1-3):365       1 Citation
1Gamma delta T cells in normal spleen assist immunized alpha beta T cells in the adoptive cell transfer of contact sensitivity. Effect of Bordetella pertussis, cyclophosphamide, and antibodies to determinants on suppressor cells. (Askenase PW, Szczepanik M, Ptak M, Paliwal V, Ptak W) J Immunol 1995 Apr 15;154(8):3644-53       40 Citations
12-chlorodeoxyadenosine induces durable remissions and prolonged suppression of CD4+ lymphocyte counts in patients with hairy cell leukemia. (Seymour JF, Kurzrock R, Freireich EJ, Estey EH) Blood 1994 May 15;83(10):2906-11       200 Citations
1Mimicry of heart cell surface epitopes in primary anti-Trypanosoma cruzi Lyt 2+ T lymphocytes. (Felix JC, von Kreuter BF, Santos-Buch CA) Clin Immunol Immunopathol 1993 Aug;68(2):141-6       7 Citations
1Preservation of lymphokine-activated killer activity following T cell depletion of human bone marrow. (Drobyski WR, Piaskowski V, Ash RC, Casper JT, Truitt RL) Transplantation 1990 Oct;50(4):625-32       11 Citations